Sound Ear Check (SEC) in Hearing Diagnostics in Young Children

Sponsor
Vesa Lahdes (Other)
Overall Status
Recruiting
CT.gov ID
NCT05535634
Collaborator
(none)
100
1
76
1.3

Study Details

Study Description

Brief Summary

Study Sound Ear Check (SEC) hearing test among 3-10 years old otherwise healthy children referred to tympanostomy tube placement. SEC test prior surgery (with middle ear fluid) and at 1 month control visit (dry middle ear with ventilation tube). Otitis media 6 questionnaire prior surgery and at the 1 month control visit.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Sound Ear Check

Detailed Description

Sound Ear Check (SEC) is an automated tablet-based self-test that uses common nonspeech sounds (ecological sounds) that are accompanied by pictures that are easily recognizable even for younger children.

Before TTI operation, each participant will be tested with SEC using normal (dichotic) sounds and antiphasic sounds. Results will be compared to middle ear findings and the test will be repeated one month after the operation when the middle ears are checked to be dry (with a ventilation tube). At the time of the myringotomy during TTI operation, possible middle ear fluid will be classified as serous (transparent, clear), mucous (thick) or purulent (consisting of pus). A tympanometry will be performed within the same visit as the SEC measurement before the TTI operation. At the time of tympanometric examination, each participant will be classified as cooperative (sittings still, not crying, not resisting) or non-cooperative. Tympanometric findings will be classified after the Jerger classification. SEC and tympanometric testing is designed to be performed at the same visit as TTI operation as patients will be waiting for the operation at the ward. Medical history of the study patients will be collected from the hospital patient records and through interview and questionnaires to the subjects. Ear related quality of life questionnaire (OM-6) will be performed at the beginning of the study and the one month control visit. Questionnaires are collected using web-based REDCap -software (Research Electronic Data Capture).

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Sound Ear Check (SEC) in Hearing Diagnostics in Young Children Undergoing Tympanostomy Tube Insertion
Actual Study Start Date :
Aug 31, 2022
Anticipated Primary Completion Date :
Dec 31, 2028
Anticipated Study Completion Date :
Dec 31, 2028

Arms and Interventions

Arm Intervention/Treatment
Children referred for tympanostomy tube insertion

Study Sound Ear Check (SEC) hearing test among 3-10 years old otherwise healthy children referred to tympanostomy tube placement. SEC test prior surgery (with middle ear fluid) and at 1 month control visit (dry middle ear with ventilation tube). Otitis media 6 questionnaire prior surgery and at the 1 month control visit.

Diagnostic Test: Sound Ear Check
Hearing test, measurement of the input impedance of the middle-ear transmission system
Other Names:
  • Tympanometry
  • Outcome Measures

    Primary Outcome Measures

    1. SNR [1-2 months]

      Signal to noise ratio

    Secondary Outcome Measures

    1. Otitis media 6 questionnaire [1-2 months]

      questionnaire

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    3 Years to 10 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Finnish speaking (child and parent)
    Exclusion Criteria:
    • Prior sensorineural hearing loss

    • developmental disorder

    • Prior ear surgery (except tympanostomy insertion)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Turku University Hospital, Department of Otorhinolaryngology and head and neck surgery Turku Finland

    Sponsors and Collaborators

    • Vesa Lahdes

    Investigators

    • Principal Investigator: Lotta Haavisto, PhD, Hospital District of Southwest Finland

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vesa Lahdes, M.D., Turku University Hospital
    ClinicalTrials.gov Identifier:
    NCT05535634
    Other Study ID Numbers:
    • T9/2022
    First Posted:
    Sep 10, 2022
    Last Update Posted:
    Sep 10, 2022
    Last Verified:
    Sep 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 10, 2022